Therapeutic Goods Administration says the risk to patients using the mesh products to treat pelvic floor organ prolapse outweighs the benefits Transvaginal mesh products used by surgeons to treat pelvic organ prolapse fill been quietly banned overnight by Australia’s medical devices regulator,which found the products are too risky.
In an update posted on its website, the Therapeutic Goods Administration said the move followed its review of the latest international studies and an examination of the clinical evidence for each product supplied in Australia. Continue reading...
Source: guardian.co.uk